Kenvue Inc. (NYSE:KVUE) Shares Acquired by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. increased its stake in shares of Kenvue Inc. (NYSE:KVUE) by 11.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,852,206 shares of the company’s stock after purchasing an additional 1,886,917 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Kenvue were worth $397,945,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in KVUE. Empirical Finance LLC purchased a new stake in shares of Kenvue in the third quarter valued at $336,000. UniSuper Management Pty Ltd purchased a new position in shares of Kenvue during the 3rd quarter worth about $35,544,000. Citizens Business Bank purchased a new stake in Kenvue in the third quarter valued at approximately $2,507,000. Fifth Third Bancorp grew its holdings in Kenvue by 35.3% in the fourth quarter. Fifth Third Bancorp now owns 277,580 shares of the company’s stock valued at $5,976,000 after purchasing an additional 72,435 shares during the period. Finally, Clearbridge Investments LLC increased its position in Kenvue by 364.6% during the third quarter. Clearbridge Investments LLC now owns 484,321 shares of the company’s stock worth $9,725,000 after purchasing an additional 380,071 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have weighed in on KVUE shares. Royal Bank of Canada lowered their price objective on shares of Kenvue from $25.00 to $24.00 and set an “outperform” rating for the company in a research note on Friday, February 9th. JPMorgan Chase & Co. lowered their price target on Kenvue from $25.00 to $24.00 and set an “overweight” rating for the company in a research report on Friday, February 9th. William Blair started coverage on Kenvue in a research note on Wednesday, April 3rd. They set a “market perform” rating for the company. Sanford C. Bernstein assumed coverage on Kenvue in a research note on Thursday, April 11th. They issued an “underperform” rating and a $18.00 price objective on the stock. Finally, The Goldman Sachs Group began coverage on shares of Kenvue in a research report on Friday, March 1st. They set a “neutral” rating and a $20.00 target price for the company. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $24.85.

Kenvue Trading Up 1.2 %

Shares of NYSE KVUE traded up $0.24 during midday trading on Wednesday, reaching $20.32. 13,368,911 shares of the company’s stock were exchanged, compared to its average volume of 17,001,166. The company has a quick ratio of 0.78, a current ratio of 1.12 and a debt-to-equity ratio of 0.69. Kenvue Inc. has a 52-week low of $17.82 and a 52-week high of $27.80. The business’s fifty day moving average price is $19.85 and its two-hundred day moving average price is $20.11.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Tuesday, May 7th. The company reported $0.28 earnings per share for the quarter, beating analysts’ consensus estimates of $0.25 by $0.03. Kenvue had a return on equity of 15.62% and a net margin of 9.87%. The firm had revenue of $2.89 billion during the quarter, compared to analyst estimates of $3.79 billion. The business’s revenue for the quarter was down 24.9% on a year-over-year basis. Sell-side analysts forecast that Kenvue Inc. will post 1.15 EPS for the current year.

Kenvue Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 22nd. Investors of record on Wednesday, May 8th will be issued a $0.20 dividend. The ex-dividend date is Tuesday, May 7th. This represents a $0.80 annualized dividend and a yield of 3.94%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.